Scopolamine and Pseudomembranous colitis - a phase IV clinical study of FDA data
Summary:
Pseudomembranous colitis is reported as a side effect among people who take Scopolamine (scopolamine), especially for people who are female, 50-59 old, also take Elavil,.
The phase IV clinical study analyzes which people have Pseudomembranous colitis when taking Scopolamine. It is created by eHealthMe based on reports of 4,933 people who have side effects when taking Scopolamine from the FDA, and is updated regularly.
What is Scopolamine?
Scopolamine has active ingredients of scopolamine. eHealthMe is studying from 4,945 Scopolamine users. Check the latest studies of Scopolamine.
What is Pseudomembranous colitis?
Pseudomembranous colitis (antibiotic-associated diarrhoea (aad), is an infection of the colon) is found to be associated with 428 drugs and 934 conditions by eHealthMe. Check the latest studies of Pseudomembranous colitis.
4,933 people reported to have side effects when taking Scopolamine.
Among them, 12 people (0.24%) have Pseudomembranous colitis.
Among these 12 people:
What is the gender of people who have Pseudomembranous colitis when taking Scopolamine? *
- female: 91.67 %
- male: 8.33 %
What is the age of people who have Pseudomembranous colitis when taking Scopolamine? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
What are other drugs people take besides Scopolamine? *
- Zometa: 12 people, 100.00%
- Ms Contin: 12 people, 100.00%
- Ambien: 12 people, 100.00%
- Aromasin: 12 people, 100.00%
- Ativan: 12 people, 100.00%
- Avastin: 12 people, 100.00%
- Biaxin: 12 people, 100.00%
- Celebrex: 12 people, 100.00%
- Doxil: 12 people, 100.00%
- Elavil: 12 people, 100.00%
What are other side effects people have besides Pseudomembranous colitis? *
- Wound Infection Staphylococcal: 12 people, 100.00%
- Neuropathy Peripheral (surface nerve damage): 12 people, 100.00%
- Metastases To Bone (cancer spreads to bone): 12 people, 100.00%
- Jaw Fracture: 12 people, 100.00%
- Herpes Simplex (herpes simplex is a common viral infection): 12 people, 100.00%
- Headache (pain in head): 12 people, 100.00%
- Haematoma (collection of blood outside the blood vessels): 12 people, 100.00%
- General Physical Health Deterioration (weak health status): 12 people, 100.00%
- Gastritis (inflammation of stomach): 12 people, 100.00%
- Fungal Infection: 12 people, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Scopolamine and have Pseudomembranous colitis?
- Check whether Pseudomembranous colitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Scopolamine:
- Scopolamine (4,945 reports)
Pseudomembranous colitis treatments and more:
- Pseudomembranous colitis (3,347 reports)
How severe was Pseudomembranous colitis and when was it recovered:
Expand to all the drugs that have ingredients of scopolamine:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Scopolamine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Pseudomembranous colitis:
- Pseudomembranous colitis (428 drugs)
Browse all the conditions that are associated with Pseudomembranous colitis:
- Pseudomembranous colitis (934 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on scopolamine (the active ingredients of Scopolamine) and Scopolamine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
No recent updates.